Skip to main content

Animations

MJFF Publications

4961 - 4970 of 8654 Results
Title
Year
  • Year
  • 2013
  • 2014
  • 2015
  • 2009
  • 2018
  • 2018
  • 2012
  • 2009
  • 2012
  • 2014
  • Summary Details
    OPEN
    Title: Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR-γAgonist against MPTP
    Journal Name: PPAR Research
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2013/582809
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Clinicopathological Outcomes of Prospectively Followed Normal Elderly Brain Bank Volunteers
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/nen.0000000000000046
    Citation Count: 79
  • Summary Details
    OPEN
    Title: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-015-0404-4
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Unexpected expression of α- and β-globin in mesencephalic dopaminergic neurons and glial cells
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0813216106
    Citation Count: 256
  • Summary Details
    OPEN
    Title: Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0062-4
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Cognitive training for freezing of gait in Parkinson’s disease: a randomized controlled trial
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0052-6
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Pantothenate kinase‐associated neurodegeneration is not a synucleinopathy
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: unspecified-oa
    DOI - Digital Object Identifier: 10.1111/j.1365-2990.2012.01269.x
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Long-term Transgene Expression in the Central Nervous System Using DNA Nanoparticles
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/mt.2009.2
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Caffeine and risk of Parkinson's disease in a large cohort of men and women
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25076
    Best OA location URL:
    Citation Count: 183
  • Summary Details
    OPEN
    Title: Isolation and characterization of antibody fragments selective for toxic oligomeric tau
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.12.002
    Citation Count: 27
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.